Donald Zurbay
CIK: 0001341608
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (16 total)
- Jun 15, 2026LIVN
LivaNova PLC
Award(A)DirectRestricted Stock Units
2.4K shares- - Jun 15, 2026LIVN
LivaNova PLC
Exercise(M)Direct2.6K shares- - Jun 15, 2026LIVN
LivaNova PLC
Tax Payment(F)Direct308 shares at avg. $79.70$25K - Jun 4, 2026SGHT
Sight Sciences, Inc.
Award(A)Direct28.3K shares- - Jun 3, 2026XRAY
DENTSPLY SIRONA Inc.
Award(A)Direct22.8K shares- - Jan 26, 2026XRAY
DENTSPLY SIRONA Inc.
Award(A)Direct6.9K shares- - Sep 15, 2025LIVN
LivaNova PLC
Award(A)DirectRestricted Stock Units
2.6K shares- - Jun 5, 2025SGHT
Sight Sciences, Inc.
Award(A)Direct31K shares- - Apr 17, 2025PDCO
PATTERSON COMPANIES, INC.
Award(A)Direct60.1K shares- - Apr 17, 2025PDCO
PATTERSON COMPANIES, INC.
Award(A)Direct94.5K shares- - Apr 17, 2025PDCO
PATTERSON COMPANIES, INC.
Disposition(D)Direct398.2K shares- - Apr 17, 2025PDCO
PATTERSON COMPANIES, INC.
Disposition(D)Indirect1.2K shares- - Apr 17, 2025PDCO
PATTERSON COMPANIES, INC.
Award(A)Direct20.8K shares- - Dec 9, 2024PDCO
PATTERSON COMPANIES, INC.
Sale(S)Direct2K shares at avg. $23.08$45K - Dec 5, 2024PDCO
PATTERSON COMPANIES, INC.
Tax Payment(F)Direct5.4K shares at avg. $22.83$123K - Sep 17, 2024SILK
Silk Road Medical Inc
Disposition(D)Direct12.6K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 15, 2026 |  LIVN LivaNova PLC | Award(A) Restricted Stock Units | 2,383 | - | - | Direct |
| Jun 15, 2026 | LIVN LivaNova PLC | Exercise(M) | 2,560 | - | $0 | Direct |
| Jun 15, 2026 | LIVN LivaNova PLC | Tax Payment(F) | 308 | $79.70 | $24,548 | Direct |
| Jun 4, 2026 |  SGHT Sight Sciences, Inc. | Award(A) | 28,261 | - | $0 | Direct |
| Jun 3, 2026 |  XRAY DENTSPLY SIRONA Inc. | Award(A) | 22,822 | - | $0 | Direct |
| Jan 26, 2026 | XRAY DENTSPLY SIRONA Inc. | Award(A) | 6,871 | - | $0 | Direct |
| Sep 15, 2025 | LIVN LivaNova PLC | Award(A) Restricted Stock Units | 2,560 | - | - | Direct |
| Jun 5, 2025 | SGHT Sight Sciences, Inc. | Award(A) | 30,952 | - | - | Direct |
| Apr 17, 2025 |  PDCO PATTERSON COMPANIES, INC. | Award(A) | 60,132 | - | - | Direct |
| Apr 17, 2025 | PDCO PATTERSON COMPANIES, INC. | Award(A) | 94,477 | - | - | Direct |
| Apr 17, 2025 | PDCO PATTERSON COMPANIES, INC. | Disposition(D) | 398,185 | - | - | Direct |
| Apr 17, 2025 | PDCO PATTERSON COMPANIES, INC. | Disposition(D) | 1,243 | - | - | Indirect |
| Apr 17, 2025 | PDCO PATTERSON COMPANIES, INC. | Award(A) | 20,840 | - | - | Direct |
| Dec 9, 2024 | PDCO PATTERSON COMPANIES, INC. | Sale(S) | 1,962 | $23.08 | $45,278 | Direct |
| Dec 5, 2024 | PDCO PATTERSON COMPANIES, INC. | Tax Payment(F) | 5,374 | $22.83 | $122,688 | Direct |
| Sep 17, 2024 |  SILK Silk Road Medical Inc | Disposition(D) | 12,610 | - | $0 | Direct |
1-16 of 16 transactions
About Zurbay Donald
Zurbay Donald (SEC CIK 0001341608) files insider reports with the SEC as Director of LivaNova PLC (LIVN), Director of DENTSPLY SIRONA Inc. (XRAY) and Director of Sight Sciences, Inc. (SGHT). Signal8 also holds filings tied to 2 other companies.
Signal8 holds 11 ownership filings by Zurbay Donald (2 Form 3, 9 Form 4), filed between Sep 18, 2024 and Jun 17, 2026. Those filings report 16 transactions, from Sep 17, 2024 to Jun 15, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Zurbay Donald's filings is in MENLO PARK, CA.
Recent filings by Zurbay Donald
- Jun 15, 2026: Grant or award of LIVN derivative securities (Form 4, code A).
- Jun 15, 2026: Option exercise of LIVN shares (Form 4, code M).
- Jun 15, 2026: Tax withholding of LIVN shares (Form 4, code F).
- Jun 4, 2026: Grant or award of SGHT shares (Form 4, code A).
- Jun 3, 2026: Grant or award of XRAY shares (Form 4, code A).
Other insiders filing for LivaNova PLC (LIVN)
- Liddy Anne M., Chief Legal Officer
- Bianchi Francesco, Director
- Story Brooke, Director
- Tezel Ahmet, Chief Innovation Officer
- Folli Stefano, President, Cardiopulmonary
- WILVER PETER M, Director